What You Should Know:

您应该知道：

– Wellinks, the leader in virtual-led cardiopulmonary care, has acquired Spire Health in a non-cash transaction.

–虚拟led心肺护理的领导者Wellinks通过非现金交易收购了Spire Health。

– This strategic move merges Spire’s cutting-edge patient monitoring technology with Wellinks’ specialized virtual care model, establishing a first-of-its-kind, fully integrated Predictive Patient Care company.

–这一战略性举措将Spire的尖端患者监测技术与Wellinks的专业虚拟护理模式相结合，建立了首家全面集成的预测性患者护理公司。

Addressing the Costly Burden of COPD and CHF

解决COPD和CHF的昂贵负担

Chronic Obstructive Pulmonary Disease (COPD) and Congestive Heart Failure (CHF) represent significant challenges in the U.S. healthcare system, affecting millions and costing billions annually. The majority of these expenses stem from exacerbations that lead to emergency department visits and hospitalizations.

慢性阻塞性肺疾病（COPD）和充血性心力衰竭（CHF）是美国医疗保健系统面临的重大挑战，每年影响数百万人，花费数十亿美元。这些费用中的大多数来自导致急诊科就诊和住院的恶化。

Wellinks’ Predictive Patient Care model aims to tackle these issues by identifying potential complications before they escalate, enabling timely interventions and reducing the need for costly hospitalizations..

Wellinks的预测性患者护理模式旨在通过在潜在并发症升级之前识别潜在并发症来解决这些问题，从而能够及时干预并减少昂贵的住院治疗需求。。

Predictive Patient Care: Revolutionizing Care Management

Wellinks’ Predictive Patient Care utilizes advanced predictive analytics to provide providers with insights and clinical interventions to prevent exacerbations and complications. By intervening early, patients can remain at home or receive treatment in more cost-effective settings, leading to improved outcomes and reduced costs for both payers and providers..

Wellinks的预测性患者护理利用先进的预测分析为提供者提供见解和临床干预措施，以防止病情恶化和并发症。通过早期干预，患者可以留在家中或在更具成本效益的环境中接受治疗，从而改善结果并降低支付者和提供者的成本。。

“We are thrilled to welcome Spire professionals into our organization, while also adding their amazing technology into our care models,” said Stacie Bratcher, CEO of Wellinks. “By uniting these companies, we are creating something entirely novel — Predictive Patient Care. Wellinks will now be able to passively monitor cardiopulmonary patients while leveraging machine learning to predict potential complications, often before the patient experiences symptoms.

Wellinks首席执行官斯泰西·布拉彻（StacieBratcher）表示：“我们很高兴欢迎Spire专业人士加入我们的组织，同时也将他们令人惊叹的技术添加到我们的护理模式中。”。“通过联合这些公司，我们正在创造一种全新的方式-预测性患者护理。Wellinks现在将能够被动监测心肺患者，同时利用机器学习来预测潜在的并发症，通常在患者出现症状之前。

These findings, combined with our proprietary clinical processes will then provide payors and providers suggested interventions based on validated treatment pathways. This highly integrated approach to monitoring and treating cardiopulmonary patients will be a first of its kind.”.

这些发现与我们专有的临床流程相结合，将为付款人和提供者提供基于有效治疗途径的建议干预措施。这种高度综合的监测和治疗心肺患者的方法将是同类方法中的首次。”。